SLA型3D打印技术制备盐酸文拉法辛-盐酸氟西汀多层片 <sup>Δ</sup>

徐雷; 潘偲莹; 陈红梅; 杨庆良; 杨根生

doi:10.6039/j.issn.1001-0408.2024.13.10

您当前的位置：

首页 >

文章列表页 >

SLA型3D打印技术制备盐酸文拉法辛-盐酸氟西汀多层片 ^Δ

药学研究 | 更新时间：2024-07-10

- SLA型3D打印技术制备盐酸文拉法辛-盐酸氟西汀多层片 ^Δ
- Preparation of venlafaxine hydrochloride and fluoxetine hydrochloride multilayer tablets by stereolithography 3D printing technology
- 中国药房 2024年35卷第13期页码：1600-1604
- 作者机构：
  
  1.浙江中医药大学附属杭州市中医院临床药学室，杭州　310007
  2.浙江工业大学药学院，杭州　310014
- 作者简介：
  
  药师，博士。研究方向：药物新剂型、临床药学。电话：0571-85827867。E-mail：leixuhztcm@163.com
  教授，博士生导师，博士。研究方向：药物新剂型与新技术。电话：0571-88871077。E-mail：yanggs@zjut.edu.cn
- 基金信息：
  
  浙江省自然科学基金项目(LY20B060007)
- DOI：10.6039/j.issn.1001-0408.2024.13.10
  中图分类号： R943
- 纸质出版日期：2024-07-15，
  
  收稿日期：2024-01-30，
  
  修回日期：2024-05-17，
- 稿件说明：
扫描看全文
徐雷,潘偲莹,陈红梅等.SLA型3D打印技术制备盐酸文拉法辛-盐酸氟西汀多层片 ^Δ[J].中国药房,2024,35(13):1600-1604.

XU Lei,PAN Siying,CHEN Hongmei,et al.Preparation of venlafaxine hydrochloride and fluoxetine hydrochloride multilayer tablets by stereolithography 3D printing technology[J].ZHONGGUO YAOFANG,2024,35(13):1600-1604.
徐雷,潘偲莹,陈红梅等.SLA型3D打印技术制备盐酸文拉法辛-盐酸氟西汀多层片 ^Δ[J].中国药房,2024,35(13):1600-1604. DOI： 10.6039/j.issn.1001-0408.2024.13.10.

XU Lei,PAN Siying,CHEN Hongmei,et al.Preparation of venlafaxine hydrochloride and fluoxetine hydrochloride multilayer tablets by stereolithography 3D printing technology[J].ZHONGGUO YAOFANG,2024,35(13):1600-1604. DOI： 10.6039/j.issn.1001-0408.2024.13.10.

摘要

目的

采用立体光刻成型（SLA）3D打印技术制备盐酸文拉法辛-盐酸氟西汀多层片，并进行质量评价和体外释放考察。

方法

以盐酸文拉法辛/盐酸氟西汀、光聚合单体PEGDA 400、致孔剂PEG 300、光引发剂TPO和光吸收剂柠檬黄等组成处方，采用SLA型3D打印技术制备外径10 mm、内径5 mm、厚度6 mm的盐酸文拉法辛-盐酸氟西汀多层片，然后对其外观、三维尺寸、重量均匀度、药物含量、内部结构特征以及体外释放特性进行考察。

结果

该多层片的打印成型性良好，边缘平滑圆整，大小、厚度均匀，外径、内径、厚度分别为（10.06±0.26）、（4.94±0.06）、（5.80±0.12） mm（RSD分别为2.58%、1.21%、2.07%，

＝20）；重量差异符合药典要求；两药含量分别为（7.96±0.09）、（11.26±0.46） mg/片。X射线衍射表征和扫描电镜表征结果显示，该

多层片中两种药物分子以无定形结构存在，盐酸文拉法辛层溶出后产生明显的孔道结构，而盐酸氟西汀层未出现孔道结构。盐酸文拉法辛层和盐酸氟西汀层在24 h时的累积释放率分别为（91.88±0.94）%、（106.25±1.28）%，符合Rigter-Peppas释放模型。

结论

本研究采用SLA型3D打印技术成功制备了盐酸文拉法辛-盐酸氟西汀多层片，该多层片成型性良好，且符合Rigter-Peppas释放模型。

Abstract

OBJECTIVE

To prepare venlafaxine hydrochloride and fluoxetine hydrochloride multiplayer tablets by stereolithography （SLA） 3D printing technology， and to conduct its quality evaluation and

in vitro

release investigation.

METHODS

Using venlafaxine hydrochloride/fluoxetine hydrochloride， photopolymerization monomer PEGDA 400， porogen PEG 300， photoinitiator TPO and light absorber citrine as formulation， SLA 3D printer technology was employed to prepare venlafaxine hydrochloride and fluoxetine hydrochloride multiplayer tablets， with outer diameter of 10 mm， inner diameter of 5 mm， and thickness of 6 mm. Moreover， the tablets’ appearance， three-dimensional dimensions， weight uniformity， drug content， internal structural characteristics and

in vitro

release characteristics were all investigated.

RESULTS

The multilayer tablets had good printing formability， smooth and round edges， and uniform size and thickness； the outer diameter， inner diameter and thickness were （10.06±0.26），（4.94±0.06），（5.80±0.12） mm （RSD＝2.58%， 1.21%， 2.07%，

＝20）， and the weight difference all met the requirements. The contents of venlafaxine hydrochloride and fluoxetine hydrochloride were （7.96±0.09） and （11.26±0.46） mg/tablet， respectively. The results of X-ray diffraction and scanning electron microscopy characterization showed that the two drug molecules in the multilayer film existed in an amorphous structure； after the dissolution of the venlafaxine hydrochloride layer， a clear pore structure was formed， while the fluoxetine hydrochloride layer did not show any pore structure. According to the relea

se curve， 24 h accumulative release rates of venlafaxine hydrochloride layer and fluoxetine hydrochloride layer were（91.88±0.94）% and （106.25±1.28）%， which were in line with Rigter-Peppas release model.

CONCLUSIONS

This study successfully prepared venlafaxine hydrochloride and fluoxetine hydrochloride multilayer tablets using SLA 3D printing technology； the multilayer tablets have the advantages of excellent printing formability， which are in line with Rigter-Peppas release model.

关键词

立体光刻成型3D打印技术多层片盐酸文拉法辛盐酸氟西汀个性化制剂

Keywords

3D printing technologymultilayervenlafaxine hydrochloridefluoxetine hydrochlo- ridepersonalized formulations

references

ANBESAW T，ZENEBE Y，NECHO M，et al. Prevalence of depression among students at Ethiopian universities and associated factors：a systematic review and meta-analysis[J]. PLoS One，2023，18（10）：e0288597.

HARMER C J，DUMAN R S，COWEN P J. How do antidepressants work? New perspectives for refining future treatment approaches[J]. Lancet Psychiatry，2017，4（5）：409-418.

SACHS-ERICSSON N，HAMES J L，JOINER T E，et al. Differences between suicide attempters and nonattempters in depressed older patients：depression severity，white-matter lesions，and cognitive functioning[J]. Am J Geriatr Psychiatry，2014，22（1）：75-85.

FIELD T S，GURWITZ J H，HARROLD L R，et al. Risk factors for adverse drug events among older adults in the ambulatory setting[J]. J Am Geriatr Soc，2004，52（8）：1349-1354.

ROBLES-MARTINEZ P，XU X Y，TRENFIELD S J， et al. 3D printing of a multi-layered polypill containing six drugs using a novel stereolithographic method[J]. Pharmaceutics，2019，11（6）：274.

WEI C，SOLANKI N G，VASOYA J M，et al. Development of 3D printed tablets by fused deposition modeling using polyvinyl alcohol as polymeric matrix for rapid drug release[J]. J Pharm Sci，2020，109（4）：1558-1572.

GIOUMOUXOUZIS C I，TZIMTZIMIS E，KATSAMENIS O L，et al. Fabrication of an osmotic 3D printed solid do- sage form for controlled release of active pharmaceutical ingredients[J]. Eur J Pharm Sci，2020，143：105176.

SENTHIL A，HARDIK R，KUMAR M. Design and optimization of mucoadhesive microspheres of venlafaxine HCl using 23 full factorial designs [J]. Der Pharmacia Lettre，2011，3：202-211.

苗国力，郭洪涛，刘文玲，等. 盐酸文拉法辛缓释胶囊的制备及释放度研究[J]. 山东化工，2023，52（17）：48-53.

MIAO G L，GUO H T，LIU W L，et al. Study on the preparation and release of venlafaxine hydrochloride sustained-release capsules[J]. Shandong Chem Ind，2023，52（17）：48-53.

MARONI A，MELOCCHI A，PARIETTI F，et al. 3D printed multi-compartment capsular devices for two-pulse oral drug delivery[J]. J Control Release，2017，268：10-18.

DASH S，MURTHY P N，NATH L，et al. Kinetic mode- ling on drug release from controlled drug delivery systems[J]. Acta Pol Pharm，2010，67（3）：217-223.

WANG J，GOYANES A，GAISFORD S，et al. Stereolithographic （SLA） 3D printing of oral modified-release do- sage forms[J]. Int J Pharm，2016，503（1/2）：207-212.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据

SLA型3D打印技术制备盐酸文拉法辛-盐酸氟西汀多层片 Δ

Preparation of venlafaxine hydrochloride and fluoxetine hydrochloride multilayer tablets by stereolithography 3D printing technology

DOI：10.6039/j.issn.1001-0408.2024.13.10

摘要

Abstract

关键词

Keywords

references

SLA型3D打印技术制备盐酸文拉法辛-盐酸氟西汀多层片 ^Δ